Liang BA.* Measuring the Impact of Counterfeit Drugs: Applying the Patient Safety Reporting System Approach. Proceedings of the OECD/WIPO meeting on measurement of counterfeiting and piracy, 17-18 October 2005.

October 17, 2005

Counterfeit Drugs  At least $32/€27 billion annually. $88/€73 million a day.  Estimates: grow to $75/€62 billion annually in 5 years.  Up to 60% of drugs in developing countries are counterfeit  Up to 90% artenusate in Southeast Asia fake.  Up to 20% of drugs sold in some developed countries counterfeit.  Up to 15% of all drugs…

[...]

Liang BA.* Over The Virtual and Geographic Borders: Understanding Importation and Counterfeit Drugs. Cal W Int Law J. 2005 Jun 3;36(1):7-18

June 3, 2005

Abstract. U.S. citizens depend extensively on medicines for health and quality of life. Yet a major problem attends the drug supply: counterfeit medicines. Although currently the United States has a relatively safe, closed system, it has not been immune to counterfeits, and harm associated with counterfeits has occurred here. Further, because terrorist activities have been…

[...]

Liang BA.* International Drug Importation: Issues in Public Policy, Patient Safety, and the Public Health. Cal W Int Law J. 2005 Jun 3;36(1):1-6

June 3, 2005

Abstract. This issue of the California Western International Law Journal memorializes the proceedings of the First Annual San Diego Health Policy Conference, International Drug Importation: Issues in Public Policy, Patient Safety, and the Public Health. Leaders from medicine, law, public policy, academia, and patient care groups gathered together on June 3-4, 2005 to discuss the…

[...]